Longevity NewLimit ‘close’ to clinic-ready epigenetic reprogramming therapyBy adminNovember 28, 20250 Liver rejuvenation program produces a ‘lead payload’ as biotech begins its journey towards human clinical trials. After several years of…
Longevity First partial epigenetic reprogramming therapy for the brain?By adminSeptember 25, 20250 YouthBio receives positive FDA feedback on therapy designed to restore youthful gene expression patterns and address drivers of Alzheimer’s. Epigenetic…
